
### [NCIT:C4450](http://purl.obolibrary.org/obo/NCIT_C4450)
**Label:** Large Cell Lung Carcinoma

**Subclasses:** [NCIT:C8755](http://purl.obolibrary.org/obo/NCIT_C8755) (Stage I Large Cell Lung Carcinoma AJCC v7), [NCIT:C6876](http://purl.obolibrary.org/obo/NCIT_C6876) (Large Cell Lung Carcinoma with Rhabdoid Phenotype), [NCIT:C8756](http://purl.obolibrary.org/obo/NCIT_C8756) (Stage IV Large Cell Lung Carcinoma AJCC v7), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C8753](http://purl.obolibrary.org/obo/NCIT_C8753) (Recurrent Large Cell Lung Carcinoma), [NCIT:C4451](http://purl.obolibrary.org/obo/NCIT_C4451) (Large Cell Lung Carcinoma, Clear Cell Variant), [NCIT:C7266](http://purl.obolibrary.org/obo/NCIT_C7266) (Basaloid Large Cell Lung Carcinoma), [NCIT:C5672](http://purl.obolibrary.org/obo/NCIT_C5672) (Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C9257](http://purl.obolibrary.org/obo/NCIT_C9257) (Stage III Large Cell Lung Carcinoma AJCC v7), [NCIT:C6660](http://purl.obolibrary.org/obo/NCIT_C6660) (Stage II Large Cell Lung Carcinoma AJCC v7), [NCIT:C136493](http://purl.obolibrary.org/obo/NCIT_C136493) (Large Cell Lung Carcinoma by AJCC v7 Stage), [NCIT:C45519](http://purl.obolibrary.org/obo/NCIT_C45519) (Lymphoepithelioma-Like Lung Carcinoma), [NCIT:C35758](http://purl.obolibrary.org/obo/NCIT_C35758) (Stage 0 Large Cell Lung Carcinoma AJCC v6 and v7), 

**Class expressions from DL-Learner:**

- [NCIT:C41361](http://purl.obolibrary.org/obo/NCIT_C41361) (KRAS Gene Mutation) 62.50%
- [NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation) 62.50%
- [NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion) 62.50%
- Thing 51.30%
- [NCIT:C42585](http://purl.obolibrary.org/obo/NCIT_C42585) (Epithelial Differentiation) 44.61%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 41.94%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 41.77%
- [NCIT:C43573](http://purl.obolibrary.org/obo/NCIT_C43573) (Glandular Differentiation) 41.37%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 40.58%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 39.85%
- [NCIT:C42095](http://purl.obolibrary.org/obo/NCIT_C42095) (Tissue Differentiation) 37.91%
- [NCIT:C42078](http://purl.obolibrary.org/obo/NCIT_C42078) (Lesion by Morphology) 26.37%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 18.75%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 16.14%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 16.04%


